- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07400887
Knowledge About and Attitudes Towards Non-binary Persons in Flanders (Part 1: Quantitative Study)
Onderzoek Naar de Kennis Over en Houding Ten Opzichte Van Non-binaire Personen in Vlaanderen (Deel 1, Kwantitatief)
The goal of this observational study is to investigate the knowledge about and attitudes towards non-binary individuals in Flemish adults. The main questions it aims to answer are:
To which degree does the Flemish population have knowledge about non-binary persons? What are the attitudes of the Flemish population towards non-binary persons? What factors influence the attitudes towards non-binary persons? Furthermore, the aim is to create a survey to measure knowledge about and attitudes towards non-binary persons.
Participants will complete an online survey.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ghent, Belgium, 9000
- Universitair Ziekenhuis Gent
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18+ years old
- Living in Flanders or the Netherlands
- enrolled in Ipsos ISO-certified panel
Exclusion Criteria:
- 17 or <17 years old
- not living in Flanders or the Netherlands
- not enrolled in Ipsos ISO-certified panel
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Flemish participants
1000 Flemish adult participants, randomly selected from Ipsos panel.
No intervention.
|
|
Dutch participants
1000 Dutch adult participants, randomly selected from Ipsos panel.
No intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attitudes towards non-binary persons
Time Frame: At the time of enrollment
|
An online survey of 16 questions to measure attitudes was developed based on existing literature.
A scale of 15 questions was then developed to make follow-up measurements possible.
|
At the time of enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge about non-binarity
Time Frame: At the time of enrollment
|
The online survey included questions asking about respondents' familiarity with the term "non-binary" and with non-binary persons, and about their definition of the concept
|
At the time of enrollment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Joz Motmans, University Hospital, Ghent
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ONZ-2025-0115
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-binary
-
Brigham and Women's HospitalFood and Drug Administration (FDA)Active, not recruitingAdvanced Non-squamous Non-small-cell Lung Cancer | Advanced Squamous Non Small Cell Lung CancerUnited States
-
Shanghai Huaota Biopharmaceutical Co., Ltd.Not yet recruitingNon Squamous Non-small Cell Lung CancerChina
-
National Institute on Aging (NIA)RecruitingHealthy Volunteers | Non-Healthy/Non-Frail | FrailUnited States
-
Clinica Universidad de Navarra, Universidad de...CompletedHepatectomy | Liver Metastases | Liver Metastasis | Liver Resection | Non-colorectal Liver Metastasis | Non-neuroendocrine Liver Metastasis | Non-colorectal Liver Metastases | Non-neuroendocrine Liver Metastases
-
Jonsson Comprehensive Cancer CenterTaiho Oncology, Inc.Not yet recruitingLung Non-Squamous Non-Small Cell CarcinomaUnited States
-
Victor Ortiz MallasenCompletedChronic Non-cancer Pain | Non-cancer PainSpain
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingNon-squamous Non-small Cell Lung CancerChina
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingNon-squamous Non-small Cell Lung CancerChina
-
University of Social Sciences and Humanities, WarsawWithin PropertiesRecruitingStudy Protocol Feasibility | Non Clinical Anxiety | Non Clinical Worry | Non Clinical RuminationPoland
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel